Methods for the treatment of itching comprising administering PGD2 receptor antagonist
US6506789B2 · kind B2 · utility
2Cited by
5References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 18, 2001 |
| Grant date | Jan 14, 2003 |
| Priority date | — |
| Expiry date | Jun 18, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/381
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A PGD2 receptor antagonist such as a compound of the formula (IA-a-5): a pharmaceutical acceptable salt thereof or a hydrate thereof, has an efficacious activity for the prevention or treatment of itching and is useful as a medicament.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.